Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna?
Bill of Health
JANUARY 6, 2022
By Jorge L. Contreras. The National Institutes of Health (NIH) is currently embroiled in a dispute over the ownership of patent rights to Moderna’s flagship mRNA COVID-19 vaccine (mRNA-1273). The NIH, which funded much of Moderna’s research on the COVID-19 vaccine, should be assertive in exerting control over the results of this taxpayer-funded research.
Let's personalize your content